Effects of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms on Retinal Tissue Perfusion in Mild Diabetic Retinopathy Patients Receiving the Medical Food, Ocufolin^®

References

• Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–1346. doi:10.1016/S0140-6736(05)61032-X
   PubMed Web of Science ®Google Scholar
• Angellotti E, D’Alessio D, Dawson-Hughes B, et al. Vitamin D supplementation in patients with type 2 diabetes: the vitamin D for established type 2 diabetes (DDM2) study. J Endocr Soc. 2018;2:310–321. doi:10.1210/js.2018-00015
   PubMed Web of Science ®Google Scholar
• Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76:274S–280S. doi:10.1093/ajcn/76.1.274S
   PubMed Web of Science ®Google Scholar
• Ekelund U, Franks PW, Sharp S, Brage S, Wareham NJ. Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness. Diabetes Care. 2007;30:2101–2106. doi:10.2337/dc07-0719
   PubMed Web of Science ®Google Scholar
• Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–183. doi:10.1080/09286580701396720
   PubMed Web of Science ®Google Scholar
• Grauslund J, Green A, Sjølie AK. Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. Ophthalmology. 2009;116:2170–2174. doi:10.1016/j.ophtha.2009.04.043
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60:428–431. doi:10.4103/0301-4738.100542
   PubMed Web of Science ®Google Scholar
• Keel S, Xie J, Foreman J, Van WP, Taylor HR, Dirani M. The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: the national eye health survey. Ophthalmology. 2017;124:977–984. doi:10.1016/j.ophtha.2017.02.004
   PubMed Web of Science ®Google Scholar
• Yun JS, Ko SH, Kim JH, et al. Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus. Diabetes Metab J. 2013;37:262–269. doi:10.4093/dmj.2013.37.4.262
   PubMedGoogle Scholar
• Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–1452. doi:10.1096/fj.03-1476fje
   PubMed Web of Science ®Google Scholar
• Willis JR, Doan QV, Gleeson M, et al. Vision-related functional burden of diabetic retinopathy across severity levels in the United States. JAMA Ophthalmol. 2017;135:926–932. doi:10.1001/jamaophthalmol.2017.2553
   PubMed Web of Science ®Google Scholar
• Nappo F, De RN, Marfella R, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 1999;281:2113–2118. doi:10.1001/jama.281.22.2113
   PubMed Web of Science ®Google Scholar
• Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057–1069. doi:10.7150/ijbs.7502
   PubMed Web of Science ®Google Scholar
• Qi Z, Hoffman G, Kurtycz D, Yu J. Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin. Genet Med. 2003;5:458–459. doi:10.1097/01.GIM.0000095001.12570.A8
   PubMed Web of Science ®Google Scholar
• Brustolin S, Giugliani R, Felix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res. 2010;43:1–7. doi:10.1590/S0100-879X2009007500021
   PubMed Web of Science ®Google Scholar
• Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem. 2000;46:1065–1071. doi:10.1093/clinchem/46.8.1065
   PubMed Web of Science ®Google Scholar
• Maeda M, Yamamoto I, Fukuda M, et al. MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation. Diabetes Care. 2003;26:547–548. doi:10.2337/diacare.26.2.547-a
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang H, Townsend JH, Wang J. Effects of Ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene. BMJ Open Diabetes Res Care. 2021;9:e002327. doi:10.1136/bmjdrc-2021-002327
   PubMed Web of Science ®Google Scholar
• Maeda M, Fujio Y, Azuma J. MTHFR gene polymorphism and diabetic retinopathy. Curr Diabetes Rev. 2006;2:467–476. doi:10.2174/1573399810602040467
   PubMedGoogle Scholar
• van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044–1051. doi:10.1086/301825
   PubMed Web of Science ®Google Scholar
• Binia A, Contreras AV, Canizales-Quinteros S, Alonzo VA, Tejero ME, Silva-Zolezzi I. Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism. Genes Nutr. 2014;9:421. doi:10.1007/s12263-014-0421-7
   PubMed Web of Science ®Google Scholar
• Wang X, Fu J, Li Q, Zeng D, Wei Q-Y. Geographical and ethnic distributions of the MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in Chinese populations: a meta-analysis. PLoS One. 2016;11(4):e0152414. doi:10.1371/journal.pone.0152414
   PubMed Web of Science ®Google Scholar
• Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862–866. doi:10.1093/oxfordjournals.aje.a010290
   PubMed Web of Science ®Google Scholar
• Elias MF, Brown CJ. New evidence for homocysteine lowering for management of treatment-resistant hypertension. Am J Hypertens. 2022;35:303–305. doi:10.1093/ajh/hpab194
   PubMed Web of Science ®Google Scholar
• McNulty H, Strain JJ, Hughes CF, Ward M. Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Mol Aspects Med. 2017;53:2–9. doi:10.1016/j.mam.2016.10.002
   PubMed Web of Science ®Google Scholar
• Santana BH, de Severo AC, Dos Santos Nunes MK, et al. The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients. Diabetol Metab Syndr. 2019;11:4. doi:10.1186/s13098-019-0399-9
   PubMed Web of Science ®Google Scholar
• Dong X, Wang J, Wang G, Wang J, Wang L, Du Y. MTHFR A1298C gene polymorphism on stroke risk: an updated meta-analysis. Genes Environ. 2021;43:40. doi:10.1186/s41021-021-00208-z
   PubMed Web of Science ®Google Scholar
• Shi C, Wang P, Airen S, et al. Nutritional and medical food therapies for diabetic retinopathy. Eye Vis. 2020;7:33. doi:10.1186/s40662-020-00199-y
   PubMedGoogle Scholar
• Raichle ME, Gusnard DA. Appraising the brain’s energy budget. Proc Natl Acad Sci U S A. 2002;99:10237–10239. doi:10.1073/pnas.172399499
   PubMed Web of Science ®Google Scholar
• Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:176–205. doi:10.1016/S1350-9462(00)00027-6
   Web of Science ®Google Scholar
• Kurihara T, Westenskow PD, Gantner ML, et al. Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration. Elife. 2016;5. doi:10.7554/eLife.14319
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang H, Townsend JH, Wang J. Improved conjunctival microcirculation in diabetic retinopathy patients with MTHFR polymorphisms after Ocufolin Administration. Microvasc Res. 2020;132:104066. doi:10.1016/j.mvr.2020.104066
   PubMed Web of Science ®Google Scholar
• Elias MF, Brown CJ. Medical foods for lowering homocysteine in hypertensive patients. J Clin Hypertens. 2023;25:111–114. doi:10.1111/jch.14608
   Web of Science ®Google Scholar
• Liu Z, Jiang H, Townsend JH, Wang J. Improved retinal microcirculation in mild diabetic retinopathy patients carrying MTHFR polymorphisms who received the medical food, Ocufolin((R)). Clin Ophthalmol. 2022;16:1497–1504. doi:10.2147/OPTH.S358753
   PubMed Web of Science ®Google Scholar
• Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of medical care in diabetes. Ann Intern Med. 2016;164:542–552. doi:10.7326/M15-3016
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice Pattern(R). Ophthalmology. 2020;127:66–145.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang H, Townsend JH, Wang J. Retinal tissue perfusion reduction best discriminates early stage diabetic retinopathy in patients with type 2 diabetes mellitus. Retina. 2021;41:546–554. doi:10.1097/IAE.0000000000002880
   PubMed Web of Science ®Google Scholar
• Schmidl D, Werkmeister R, Szegedi S, et al. The effect of folate supplementation on systemic homocysteine plasma concentration and ocular blood flow in patients with diabetes. Schweizerische Opthalmologische Gesellschaft (SOG) Annual conference; 2018; Friborg, Switzerland.
   Google Scholar
• Fekih-Mrissa N, Mrad M, Ibrahim H, et al. Methylenetetrahydrofolate Reductase (MTHFR) (C677T and A1298C) Polymorphisms and vascular complications in patients with type 2 diabetes. Can J Diabetes. 2017;41:366–371. doi:10.1016/j.jcjd.2016.11.007
   PubMed Web of Science ®Google Scholar
• Horigan G, McNulty H, Ward M, Strain JJ, Purvis J, Scott JM. Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-->T polymorphism in MTHFR. J Hypertens. 2010;28:478–486. doi:10.1097/HJH.0b013e328334c126
   PubMed Web of Science ®Google Scholar
• Hustad S, Schneede J, Ueland PM. Riboflavin and Methylenetetrahydrofolate Reductase. Austin, TX: Landes Bioscience; 2019.
   Google Scholar
• McAuley E, McNulty H, Hughes C, Strain JJ, Ward M. Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition. Proc Nutr Soc. 2016;75:405–414. doi:10.1017/S0029665116000197
   PubMed Web of Science ®Google Scholar
• Srour M, Putorti ML, Schwartzentruber J, et al. Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood. Muscle Nerve. 2014;50:775–779. doi:10.1002/mus.24224
   PubMed Web of Science ®Google Scholar
• O’Callaghan B, Bosch AM, Houlden H. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis. 2019;42(4):598–607. doi:10.1002/jimd.12053
   PubMed Web of Science ®Google Scholar
• Venkataswamy G. Ocular manifestations of vitamin B-complex deficiency. Br J Ophthalmol. 1967;51:749–754. doi:10.1136/bjo.51.11.749
   PubMed Web of Science ®Google Scholar
• Wang J, Brown C, Shi C, et al. Improving diabetic and hypertensive retinopathy with a medical food containing L-Methylfolate: a preliminary report. Eye Vis. 2019. doi:10.1186/s40662-019-0147-0
   Google Scholar
• Brown CJ. Preservation of retinal structure and function after cilioretinal artery occlusion: a case report. Int Med Case Rep J. 2016;9:29–34. doi:10.2147/IMCRJ.S96858
   PubMedGoogle Scholar